News in the Life Sciences Industry

SILVER SPRING, Md., Dec. 5, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration has approved three applications for first generics of Gilenya (fingolimod) capsules for the treatment of relapsing forms of multiple sclerosis (MS) in adult patients.

BOSTON, Dec. 5, 2019 /PRNewswire/ -- EIP Pharma, Inc. (www.eippharma.com), a CNS-focused therapeutics company, today announced that... Read more ››

DUBLIN, Dec. 5, 2019 /PRNewswire/ -- The Read more ››

DUBLIN, Dec. 5, 2019 /PRNewswire/ -- The Read more ››

MAUI, Hawaii, Dec. 5, 2019 /PRNewswire/ -- XRHealth, the leading provider of extended reality and therapeutic AR and VR applications for the... Read more ››

ROCKVILLE, Md., Dec. 5, 2019 /PRNewswire/ -- Screen Therapeutics LLC announces today that is has formed a partnership with Immunaccel to focus on the discovery and development of next generation cancer immunotherapies.

DUBLIN, Dec. 5, 2019 /PRNewswire/ -- The Read more ››

PALO ALTO, Calif., Dec. 5, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced that its Board of Directors has scheduled the 2020 Annual Meeting of Stockholders for February 13, 2020 with a record date of December 16, 2019. The meeting will be held at the company's headquarters located at... Read more ››

SAN JOSE, Calif., Dec. 5, 2019 /PRNewswire/ -- Integrated Device Technology, Inc. (IDT), a wholly owned subsidiary of Renesas Electronics Corporation (TSE: 6723), today introduced the industry's first integrated power management IC (PMIC) developed for small outline and un-buffered DDR5-based... Read more ››

Johnson & Johnson Names Hubert Joly, Executive Chairman of Best Buy and Mark A. Weinberger, Former EY Global Chairman and CEO to its Board of Directors

DUBLIN, Dec. 5, 2019 /PRNewswire/ -- The Read more ››

WILMINGTON, N.C., Dec. 5, 2019 /PRNewswire/ -- Hensler Surgical Products, LLC, dba Hensler Surgical Technologies (www.henslersurgical.com)... Read more ››

NEW HAVEN, Conn., Dec. 5, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohaven" or the "Company"), a clinical stage biopharmaceutical company with a portfolio of late-stage product candidates for neurological and neuropsychiatric diseases, announced today... Read more ››

SILVER SPRING, Md., Dec. 5, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration has been investigating the presence of genotoxic impurities, called nitrosamines, in some types of drugs. Over the past year and a half, several drug products including angiotensin II receptor blockers (ARBs)... Read more ››